Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
5.85
-0.09 (-1.52%)
At close: Apr 8, 2026, 4:00 PM EDT
5.95
+0.10 (1.71%)
After-hours: Apr 8, 2026, 7:11 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $68.03 million as of April 8, 2026. Its market cap has increased by 372.74% in one year.
Market Cap
68.03M
Enterprise Value
65.86M
1-Year Change
372.74%
Ranking
Category
Stock Price
$5.85
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has increased from $64.29M to $68.03M, an increase of 5.82%. That is a compound annual growth rate of 1.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 68.03M | 131.97% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 74.33M |
| Fractyl Health | 73.79M |
| BeyondSpring | 72.37M |
| XBiotech | 71.34M |
| MediciNova | 70.88M |
| Adicet Bio | 70.41M |
| InflaRx | 68.68M |
| Coeptis Therapeutics Holdings | 67.52M |